Related Experiment Video
Updated: Apr 23, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Bayesian Modeling on Microbiome Data Analysis: Application to Subgingival Microbiome Study
Yeongjin Gwon1,2, Fang Yu1, Jeffrey B Payne3,4
1Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, 984375 Nebraska Medical Center, Omaha, NE 68198‑4375, USA.
Abstract:
The study of microbiome data has been widely used to investigate associations between the abundance of microbial taxa and human diseases. Identifying and understanding these relationships precisely gives the microbiome a key role in human health, disease status, and the development of new diagnostics and targeted therapeutics. Due to its unique features such as compositional data, excessive zero counts, overdispersion, and complexed structure between taxa, undertaking effective microbiome data analytics presents numerous obstacles. To quantify covariate-taxa effects on the subgingival microbiome study, we proposed a refined Bayesian zero-inflated negative binomial (ZINB) regression model with random subject effects. This proposed approach not only accommodates inflated zero counts and overdispersion similar to the existing ZINB model developed by Jiang et al. (Biostatistics 22(3):522-540, 2021), but also accounts for subject-level heterogeneity through the inclusion of random subject effects. In addition, an efficient Markov chain Monte Carlo (MCMC) sampling algorithm was developed for Bayesian computation. Overall effects of pre-selected group variables on predicted taxa abundance were estimated and tested under the proposed model. We conduct simulation studies and demonstrate that the proposed model outperforms the competing models in achieving a better power with controlling the type I error. The usefulness of the proposed model is applied to a real subgingival microbiome study.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Methods to Assess Microbial Communities
Introduction to the Human Microbiota
Methods to Assess Microbial Populations
Development of Human Microbiota
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

